# Ustekinumab-aekn

NDC: 51759-710
Generic name: ustekinumab-aekn
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20250602

FDA application: BLA761343

## Active ingredients

- USTEKINUMAB-AEKN: 90 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51759-710"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51759-710
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=183a1dff-ef33-4ddb-ba38-f7861b0f77ad